Hingu

Names and identification

Language	Name
English	Hingu
Latin/Botanical	Ferula asafoetida

Key Phytochemical Constituents

• Ferulic acid and its esters (resin fraction)
• Sesquiterpene coumarins (e.g., farnesiferol)
• Organosulfur compounds (sec-butyl propenyl disulfide)
• Umbelliferone (coumarin derivative)
• Luteolin and other terpenoids
• Gum polysaccharides (glucose, galactose, arabinose)
• Volatile monoterpenes (alpha-pinene, beta-pinene)

How does it work?

• Antispasmodic action through relaxation of smooth muscle via calcium channel antagonism, particularly in the gastrointestinal tract
• Anti-inflammatory activity mediated by ferulic acid and sesquiterpene coumarins through inhibition of NF-kB and COX-2 pathways
• Organosulfur compounds provide antimicrobial activity by disrupting bacterial and fungal cell membrane integrity
• Volatile oil components eliminated through the lungs provide expectorant and bronchodilatory effects for respiratory conditions
• Antioxidant mechanism via free radical scavenging by ferulic acid and polyphenolic compounds, protecting against oxidative stress in liver and kidney

Which traditional uses are supported by research?

• Digestive aid for flatulence and dyspepsia - validated by double-blind RCT showing 81% improvement in functional dyspepsia symptoms
• Antispasmodic for colic and abdominal pain - confirmed through smooth muscle relaxation studies
• Expectorant for asthma and bronchitis - supported by network pharmacology and molecular docking studies identifying anti-asthmatic targets
• Antimicrobial agent against intestinal infections - validated by in vitro studies demonstrating broad-spectrum activity
• Anti-inflammatory for pain and swelling - supported by multiple preclinical studies showing COX-2 and NF-kB inhibition

What do recent clinical trials show?

• Mala KN, Thomas J, Syam DS and others 2018. Safety and Efficacy of Ferula asafoetida in Functional Dyspepsia: A Randomized, Double-Blinded, Placebo-Controlled Study. Evidence-based complementary and alternative medicine : eCAM. PMID 30224930 · doi:10.1155/2018/4813601
  In 43 subjects with functional dyspepsia, 81% of the asafoetida group showed significant improvement in overall symptom scores and quality of life compared to placebo over a 30-day period.
• Thulluri SP, Selvaraj K, Yerraguntla DP and others 2025. A Review of the Protective Effects of Ferula asafoetida on the Liver, Kidney, and Testes Against Formaldehyde-Induced Damage. Cureus. PMID 40144445 · doi:10.7759/cureus.79545
  Demonstrated hepatoprotective, nephroprotective, and reproductive-protective effects of asafoetida extract against formaldehyde-induced oxidative damage in animal models.
• Qasim M, Abdullah M, Ali Ashfaq U and others 2023. Molecular mechanism of Ferula asafoetida for the treatment of asthma: Network pharmacology and molecular docking approach. Saudi journal of biological sciences. PMID 36568408 · doi:10.1016/j.sjbs.2022.103527
  Network pharmacology analysis identified key molecular targets and signaling pathways through which asafoetida components exert anti-asthmatic effects, validating traditional use for respiratory conditions.
• Niazmand R, Razavizadeh BM 2021. Ferula asafoetida: chemical composition, thermal behavior, antioxidant and antimicrobial activities of leaf and gum hydroalcoholic extracts. Journal of food science and technology. PMID 33967312 · doi:10.1007/s13197-020-04724-8
  Characterized chemical composition and confirmed significant antioxidant capacity and broad-spectrum antimicrobial activity of both leaf and gum resin extracts.

Recent safety updates

• Likely unsafe during pregnancy as it may cause miscarriage; a case of severe methemoglobinemia was reported in a 5-week-old infant following ingestion of glycerated asafoetida solution
• Generally recognized as safe (GRAS) in food amounts; possible side effects at medicinal doses include gas, diarrhea, headache, mouth/lip swelling, and burping; animal studies suggest liver toxicity at high doses (200 mg/kg for 6 weeks)
• May interact with anticoagulant and antihypertensive medications; individuals with bleeding disorders should exercise caution due to potential anticoagulant properties

Dosage forms and preparation

Dosage Forms: Churna (powder), Vati (pill/tablet), Capsule, Arka (distillate), Bhasma (processed form)

Standard Dosage: 125-500mg powder with meals; 250-500mg Hingu Vati; typically used as culinary spice (pinch to 1/4 tsp)

Bioavailability: Ferula assa-foetida resin contains volatile sulfur compounds (disulfides) and ferulic acid. Volatile components are rapidly absorbed via GI tract and partially through pulmonary route after oral administration. Ferulic acid shows ~30-40% oral bioavailability. Traditional practice of frying in ghee (Hingu Tadka) may improve palatability and modulate release. Low doses are key as higher doses can cause GI irritation.

Optimal Timing: With meals for digestive support; before meals dissolved in warm water for bloating

Standardized Extract: Essential oil standardized to minimum 40% sec-butyl propenyl disulfide; resin extract with ferulic acid content >2%

Shelf Life: 2 years (powder in airtight container); 3 years (enteric-coated tablet); 2 years (essential oil, sealed)

Storage: Airtight containers essential (prevents odor escape and volatile loss). Cool, dry place below 25°C. Keep away from other ingredients to prevent cross-contamination of odor.

Marker Compounds: sec-Butyl propenyl disulfide, Ferulic acid, Farnesiferol A, Farnesiferol B, Umbelliprenin, 2-Butyl propenyl disulfide

Extraction Methods

• Steam distillation (essential oil, 4-20% yield)
• Hydroalcoholic extraction (70% ethanol for resin components)
• CO2 supercritical extraction for sulfur compound-rich fraction
• Traditional processing: roasting in ghee

Synergistic Combinations

• With Ajwain for carminative action
• With Sunthi (ginger) for digestive stimulation
• With Jeeraka (cumin) for flatulence relief
• With Saindhava Lavana for Vata disorders